Clinical Trial Update: Tislelizumab in Combination with Chemotherapy ± Radiotherapy for Extensive-Stage Oligometastatic Small Cell Lung Cancer. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tislelizumab with chemotherapy, with or without radiotherapy, for extensive-stage oligometastatic small cell lung cancer; recruitment h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Tislelizumab (tislelizumab)

Snippet

Sponsor: Hebei Medical University Fourth Hospital | Conditions: Small Cell Lung Cancer Extensive Stage | Phase 2 | Status: NOT_YET_RECRUITING